相关实验视频
Updated: Jan 15, 2026
05:50
Ameliorating Osteoarthritis in Mice Using Silver Nanoparticles
Published on: June 2, 2023
1.7K
复星在骨关节炎治疗中的机制和潜在的毒性风险
Haiyang Kou1, Huaiquan Liu1, Lingyan Lai1
1College of Acumox and Tuina, Guizhou University of Traditional Chinese Medicine, Gui Yang, Guizhou, China.
Journal of biochemical and molecular toxicology
|October 16, 2025
概括
ресвератрол通过向PTGS2和EGFR等关键基因,显示出对骨关节炎治疗的潜力. 它的机制涉及通过cAMP,MAPK和microRNA途径调节细胞过程.
科学领域:
- 药理学 药理学是指药理学的学科.
- 计算生物学 计算生物学
- 生物化学 生物化学
背景情况:
- 骨关节炎 (OA) 是一种退行性关节疾病,治疗选择有限.
- 复星是一种天然的多,已证明具有抗炎和抗氧化特性.
- 了解Resveratrol在OA中的作用机制对于治疗开发至关重要.
研究的目的:
- 阐明复星在骨关节炎 (OA) 治疗中的潜在作用机制.
- 为了确定关键的分子标和信号通路涉及到白醇对OA的治疗作用.
- 为了验证复星的活性成分和已识别的OA目标之间的相互作用.
主要方法:
- 网络药理学方法用于识别白醇的活性成分和点.
- 使用诸如PubChem,瑞士目标预测,GeneCards,OMIM和TTD等数据库进行生物信息分析.
- 分子对接模拟以确认复星成分与OA标之间的结合相互作用.
主要成果:
- 鉴定了resveratrol的69个活性成分和52个与OA交叉的目标.
- 对OA的主要目标包括PTGS2,EGFR,MMP9,SRC,RELA,ESR1,IGF1R和AR.
- 丰富分析显示了cAMP,MAPK和microRNA信号通路的参与.
结论:
- 复星可以通过调节细胞应激,粘附和酸化来治疗骨关节炎.
- 治疗效果通过多个信号通路进行介导,包括cAMP,MAPK和microRNA通路.
- 网络药理学和分子对接提供了关于白醇抗OA潜力的见解.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
928
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
928
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
195
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
195
01:11Renal Failure: Dose Adjustments
434
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
434
01:21Drug Distribution: Tissue Binding
3.8K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
3.8K